Aadi Bioscience logo

Aadi Bioscience share price today

(AADI)

Aadi Bioscience share price is $3.01 & ₹260.55 as on 18 Jan 2025, 2.30 'hrs' IST

$3.01

-0.12

(-3.83%)

Market is closed - opens 8 PM, 21 Jan 2025

View live Aadi Bioscience share price in Dollar and Rupees. Guide to invest in Aadi Bioscience stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Aadi Bioscience, along with analyst recommendations, forecasts, and comprehensive financials.

Aadi Bioscience share price movements

  • Today's Low: $3.00
    Today's High: $3.15

    Day's Volatility :4.75%

  • 52 Weeks Low: $1.21
    52 Weeks High: $3.81

    52 Weeks Volatility :68.26%

Aadi Bioscience Returns

PeriodAadi Bioscience IncIndex (Russel 2000)
3 Months
49.05%
0.0%
6 Months
107.28%
0.0%
1 Year
92.02%
0.0%
3 Years
-84.3%
-18.2%

Aadi Bioscience Key Statistics

in dollars & INR

Previous Close
$3.13
Open
$3.13
Today's High
$3.15
Today's Low
$2.98
Market Capitalization
$77.3M
Today's Volume
$176.9K
52 Week High
$3.812
52 Week Low
$1.21
Revenue TTM
$25.1M
EBITDA
$-63.4M
Earnings Per Share (EPS)
$-2.28
Profit Margin
-246.06%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-65.95%

How to invest in Aadi Bioscience from India?

It is very easy for Indian residents to invest directly in Aadi Bioscience from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aadi Bioscience stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aadi Bioscience or AADI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aadi Bioscience or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aadi Bioscience shares which would translate to 0.288 fractional shares of Aadi Bioscience as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aadi Bioscience, in just a few clicks!

Returns in Aadi Bioscience for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aadi Bioscience investment value today

Current value as on today

₹1,88,776

Returns

₹88,776

(+88.78%)

Returns from Aadi Bioscience Stock

₹84,663 (+84.66%)

Dollar Returns

₹4,113 (+4.11%)

Indian investors sentiment towards Aadi Bioscience

23%

Period: Oct 19, 2024 to Jan 17, 2025. Change in 30 Days versus previous period

Search volume for Aadi Bioscience on INDmoney from India has grown in the last 30 days as on Jan 18, 2025. 23% more investors are searching Aadi Bioscience in the last 30 days versus the previous period.

Global Institutional Holdings in Aadi Bioscience

  • venBio Select Advisor LLC

    11.55%

  • BML Capital Management LLC

    8.10%

  • Longwood Capital Partners LLC

    7.49%

  • EcoR1 Capital, LLC

    7.48%

  • Vanguard Group Inc

    3.10%

  • Renaissance Technologies Corp

    1.87%

Analyst Recommendation on Aadi Bioscience

Buy

    81%Buy

    18%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Aadi Bioscience(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Aadi Bioscience

What analysts predicted

Downside of 0.33%

Target:

$3.00

Current:

$3.01

Insights on Aadi Bioscience

  • Price Movement

    In the last 7 days, AADI stock has moved down by -13.1%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 5.35M → 7.21M (in $), with an average increase of 13.9% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -18.28M → -12.54M (in $), with an average increase of 20.8% per quarter
  • AADI vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 67.8% return, outperforming this stock by 155.0%

Aadi Bioscience Financials in INR & Dollars

FY18Y/Y Change
Revenue
$20.2M
-
Net Income
$-10.4M
↓ 51.42%
Net Profit Margin
-51.58%
-
FY19Y/Y Change
Revenue
$749.0K
↓ 96.28%
Net Income
$-23.3M
↑ 123.83%
Net Profit Margin
-3.1K%
↓ 3055.3%
FY20Y/Y Change
Revenue
$14.0M
↑ 1769.16%
Net Income
$-3.5M
↓ 85.05%
Net Profit Margin
-24.84%
↑ 3082.04%
FY21Y/Y Change
Revenue
$1000.0K
↓ 92.86%
Net Income
$-110.1M
↑ 3065.32%
Net Profit Margin
-11.0K%
↓ 10984.16%
FY22Y/Y Change
Revenue
$15.2M
↑ 1421.6%
Net Income
$-57.0M
↓ 48.22%
Net Profit Margin
-374.67%
↑ 10634.33%
FY23Y/Y Change
Revenue
$24.4M
↑ 60.06%
Net Income
$-65.8M
↑ 15.36%
Net Profit Margin
-270.04%
↑ 104.63%
Q2 FY23Q/Q Change
Revenue
$6.2M
↑ 5.71%
Net Income
$-18.0M
↑ 31.38%
Net Profit Margin
-289.76%
↓ 56.61%
Q3 FY23Q/Q Change
Revenue
$6.0M
↓ 3.92%
Net Income
$-16.3M
↓ 9.29%
Net Profit Margin
-273.57%
↑ 16.19%
Q4 FY23Q/Q Change
Revenue
$6.3M
↑ 6.16%
Net Income
$-16.3M
↓ 0.2%
Net Profit Margin
-257.18%
↑ 16.39%
Q1 FY24Q/Q Change
Revenue
$5.4M
↓ 15.38%
Net Income
$-18.3M
↑ 12.42%
Net Profit Margin
-341.66%
↓ 84.48%
Q2 FY24Q/Q Change
Revenue
$6.2M
↑ 15.43%
Net Income
$-14.6M
↓ 20.26%
Net Profit Margin
-236.01%
↑ 105.65%
Q3 FY24Q/Q Change
Revenue
$7.2M
↑ 16.72%
Net Income
$-12.5M
↓ 13.97%
Net Profit Margin
-173.96%
↑ 62.05%
FY18Y/Y Change
Profit
$20.2M
↓ 39417.76%
FY19Y/Y Change
Profit
$672.5K
↓ 96.66%
FY20Y/Y Change
Profit
$13.8M
↑ 1955.62%
FY21Y/Y Change
Profit
$724.0K
↓ 94.76%
FY22Y/Y Change
Profit
$13.9M
↑ 1817.27%
FY23Y/Y Change
Profit
$21.5M
↑ 55.21%
Q2 FY23Q/Q Change
Profit
$5.5M
↑ 3.9%
Q3 FY23Q/Q Change
Profit
$5.3M
↓ 5.12%
Q4 FY23Q/Q Change
Profit
$5.4M
↑ 2.6%
Q1 FY24Q/Q Change
Profit
$4.7M
↓ 12.93%
Q2 FY24Q/Q Change
Profit
$5.4M
↑ 14.89%
Q3 FY24Q/Q Change
Profit
$6.4M
↑ 18.64%
FY18Y/Y Change
Operating Cash Flow
$-5.8M
↓ 69.24%
Investing Cash Flow
$-37.9K
-
Financing Cash Flow
$48.2M
↑ 28.53%
FY19Y/Y Change
Operating Cash Flow
$-23.9M
↑ 310.68%
Investing Cash Flow
$-35.7K
↓ 5.8%
Financing Cash Flow
$8.1M
↓ 83.25%
FY20Y/Y Change
Operating Cash Flow
$-12.7M
↓ 46.75%
Investing Cash Flow
$-19.0K
↓ 46.73%
Financing Cash Flow
$1.2M
↓ 85.21%
FY21Y/Y Change
Operating Cash Flow
$-22.4M
↑ 76.55%
Investing Cash Flow
$25.2M
↓ 132310.25%
Financing Cash Flow
$141.8M
↑ 11776.38%
Q2 FY23Q/Q Change
Operating Cash Flow
$-16.8M
↓ 21.36%
Investing Cash Flow
$50.6M
↑ 209.64%
Financing Cash Flow
$313.0K
↑ 3812.5%

Aadi Bioscience Technicals Summary

Sell

Neutral

Buy

Aadi Bioscience is currently in a neutral trading position according to technical analysis indicators.

Aadi Bioscience Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Aadi Bioscience Inc logo
34.91%
107.28%
92.02%
-84.3%
-87.96%
Biontech Se logo
1.03%
30.99%
14.8%
-30.25%
208.59%
Regeneron Pharmaceuticals, Inc. logo
-2.99%
-35.2%
-25.73%
12.15%
90.6%
Vertex Pharmaceuticals Incorporated logo
-6.82%
-15.92%
-4.15%
80.63%
78.2%
Alnylam Pharmaceuticals, Inc. logo
4.72%
5.76%
35.39%
79.74%
111.19%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Aadi Bioscience Inc logo
NA
NA
NA
-2.01
-0.66
-0.35
NA
2.8
Biontech Se logo
160.8
NA
0.04
-3.2
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.14
17.14
1.04
45.02
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.11
0.48
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Aadi Bioscience Inc logo
Buy
$77.3M
-87.96%
NA
-246.06%
Biontech Se logo
Buy
$27.0B
208.59%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$76.2B
90.6%
17.14
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$107.4B
78.2%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$32.1B
111.19%
NA
-15.86%

About Aadi Bioscience

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Organization
Aadi Bioscience
Employees
53
CEO
Mr. David J. Lennon Ph.D.
Industry
Miscellaneous

Management People of Aadi Bioscience

NameTitle
Mr. David J. Lennon Ph.D.
President, CEO & Director
Mr. Scott M. Giacobello CPA
CFO, Treasurer, Investor Relations & Corporate Communications
Mr. Stephen M. Rodin J.D.
Senior VP of Legal & General Counsel
Mr. Raymond G. Steitz
Senior VP of Human Resources & Chief Human Resources Officer
Mr. Bryan Ball
Chief Technical Operations Officer

Important FAQs about investing in Aadi Bioscience from India :

What is Aadi Bioscience share price today?

Aadi Bioscience share price today stands at $3.01, Open: $3.13 ; Previous Close: $3.13 ; High: $3.15 ; Low: $3.00 ; 52 Week High: $3.81 ; 52 Week Low: $1.21. The stock opens at $3.13, after a previous close of $3.13. The stock reached a daily high of $3.15 and a low of $3.00, with a 52-week high of $3.81 and a 52-week low of $1.21.

Can Indians buy Aadi Bioscience shares?

Yes, Indians can invest in the Aadi Bioscience (AADI) from India.

With INDmoney, you can buy Aadi Bioscience at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Aadi Bioscience at zero transaction cost.

How can I buy Aadi Bioscience shares from India?

It is very easy to buy Aadi Bioscience from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aadi Bioscience be purchased?

Yes, you can buy fractional shares of Aadi Bioscience with INDmoney app.

What are the documents required to start investing in Aadi Bioscience stocks?

To start investing in Aadi Bioscience, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Aadi Bioscience

Today’s highest price of Aadi Bioscience (AADI) is $3.15.

Today’s lowest price of Aadi Bioscience (AADI) is $3.00.

What is today's market capitalisation of Aadi Bioscience

Today's market capitalisation of Aadi Bioscience AADI is 77.3M

What is the 52 Week High and Low Range of Aadi Bioscience

  • 52 Week High

    $3.81

  • 52 Week Low

    $1.21

What are the historical returns of Aadi Bioscience?

  • 1 Month Returns

    34.91%

  • 3 Months Returns

    107.28%

  • 1 Year Returns

    92.02%

  • 5 Years Returns

    -87.96%

Who is the Chief Executive Officer (CEO) of Aadi Bioscience

Mr. David J. Lennon Ph.D. is the current Chief Executive Officer (CEO) of Aadi Bioscience.